50th ASH Annual Meeting and Exposition (December 6 - 9, 2008): Myelodysplastic Syndromes

Before you can access ASH's online program, you must agree to the following:

Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
For the research and study to be eligible for presentation at the ASH annual meeting, information contained in the abstract, as well as additional data and information to be presented about the research and/or study at the annual meeting, may not be made public before the abstract has been published/presented at the ASH annual meeting.

Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

Myelodysplastic Syndromes

Saturday, December 6, 2008: 7:30 AM-9:00 AM

Halls B and C (Moscone Center)

Sunday, December 7, 2008: 7:30 AM-9:00 AM

Halls B and C (Moscone Center)

Stem Cell Aberrancy in the Development of MDS

Stephen D. Nimer, MD

Laboratory of Molecular Aspects of Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY

The Role of JAK 2 Mutations In Refractory Anemia with Ringed Sideroblasts (RARS) and Other MDS

Eva Hellström-Lindberg, MD, PhD

Dept. of Med., Div. of Hem, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden

Epigenetic Modification to Improve Outcome of Stem Cell Transplantation in MDS

Nicolaus Kröger, MD

University Hospital Hamburg-Eppendorf, Hamburg, Germany

See more of: Education Program

<< Previous Session | Next Session >>